LEADER 00542oas 2200169z- 450 001 996262799203316 035 $a(CKB)1000000000730808 035 $a(EXLCZ)991000000000730808 100 $a20180702cuuuuuuuu -u- - 101 0 $afre 200 00$aBlack Book - Department Store Industry (November 1989) 210 $cBernstein Global Wealth Management 531 $aBLACK BOOK - DEPARTMENT STORE INDUSTRY 906 $aJOURNAL 912 $a996262799203316 996 $aBlack Book - Department Store Industry (November 1989)$92424357 997 $aUNISA LEADER 03789nam 2200757 a 450 001 9910818858803321 005 20240516065104.0 010 $a9786613694409 010 $a9781280784019 010 $a1280784016 010 $a9780470720776 010 $a0470720778 010 $a9780470718476 010 $a0470718471 035 $a(CKB)1000000000688150 035 $a(EBL)703916 035 $a(OCoLC)797918501 035 $a(SSID)ssj0000715495 035 $a(PQKBManifestationID)11956101 035 $a(PQKBTitleCode)TC0000715495 035 $a(PQKBWorkID)10700628 035 $a(PQKB)10410767 035 $a(MiAaPQ)EBC703916 035 $a(Au-PeEL)EBL703916 035 $a(CaPaEBR)ebr10575632 035 $a(CaONFJC)MIL369440 035 $a(Perlego)2768082 035 $a(EXLCZ)991000000000688150 100 $a19830429d1983 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFetal antigens and cancer /$f[editors: David Evered (organizer) and Julie Whelan] 205 $a1st ed. 210 $aLondon $cPitman ;$aSummit, N.J. $cdistributed in North America by CIBA Pharmaceutical$d1983 215 $a1 online resource (274 pages) $cillustrations 225 1 $aCiba Foundation symposium ;$v96 300 $a"Symposium on Fetal antigens and cancer, held at the Ciba Foundation, London, 20-22 July 1982"--Contents page. 311 0 $a9780470664148 311 0 $a0470664142 311 0 $a9780272796603 311 0 $a0272796603 320 $aIncludes bibliographical references and indexes. 327 $aFetal antigens and cancer; Contents; Introduction; Expression of embryonic characters by malignant cells; Discussion; Embryonic antigens in malignancy and pregnancy: common denominators in immune regulation; Discussion; The T/t-complex: a family of genes controlling early embryonic surface antigens; Discussion; Fetal histocompatibility antigens and maternal immune responses; Discussion; How are tumour antigens related to normal antigens?; Discussion; The functional significance of tumour-associated cell surface alterations of embryonic and unknown origin; Discussion 327 $aHost recognition of antigens: do they induce specific antibodies? Discussion; Human chorionic gonadotropin as a model for a fetal antigen; Discussion; Can fetal antigens be used for prophylactic immunization?; Discussion; Parity and susceptibility to cancer; Discussion; Embryonic precancerous and cancerous human antigens recognized by monoclonal antibodies; Discussion; Antibodies to fetal antigens associated with rodent tumours; Discussion; General discussion; Closing remarks; Index of contributors; Subject index 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aCiba Foundation symposium ;$v96. 606 $aFetus$xCancer$vCongresses 606 $aCancer$xImmunological aspects$vCongresses 606 $aTumor antigens$vCongresses 615 0$aFetus$xCancer 615 0$aCancer$xImmunological aspects 615 0$aTumor antigens 676 $a616.99/40792 676 $a616.9940792 701 $aEvered$b David$0857127 701 $aWhelan$b Julie$0322651 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910818858803321 996 $aFetal antigens and cancer$92179117 997 $aUNINA